EBGCR Clinical Research Physician Investigators Provide Exceptional Care
Physician Investigators at EBGCR
Matthew Braddock, D.O.
ENCORE Borland Groover Clinical Research EBGCR Westside EBGCR Westside Center for Clinical ResearchEncore Borland Groover Clinical ResearchBiography
My philosophy in being a physician is that through prevention and education, my patients and I can work together to achieve their health goals. I try to incorporate this philosophy in my practice and especially in managing chronic diseases. I believe that being involved in clinical research studies helps further our ability to care for a chronically ill patient by providing insights into new and innovative drugs. I am a past department chair for Internal Medicine at St. Vincent’s Medical Center. I have been involved with Westside Center for Clinical Research as a Principal Investigator as well as a sub-Investigator on trials involving diabetes, hyperlipidemia and fatty liver disease.
EDUCATION: DEGREE:
2005-2009 Chicago College of Osteopathic Medicine DO
of Midwestern University
Downers Grove, IL
1999-2003 University of North Florida-Undergraduate BS
Jacksonville, FL
POSTDOCTORIAL TRAINING:
2009-2012 Residency: Serving as chief resident
2011-2012
St. Vincent’s Medical Center
Jacksonville, FL
CERTIFICATIONS:
Current active and unrestricted Florida License
Board Certification Family Medicine through ABMS & AOA
RESEARCH TRAINING:
06/12/2019 Medidata Rave EDC Essentials for Investigators
06/12/2019 Medidata Rave Query Management
01/14/2019 RFMH-A002a- The C-SSRS Training
01/07/2019 Allergan DDO 3101-301-002 eCOA Training (YPrime)
04/02/2018 InForm 6.1 PI Data Entry & Signature – Gemphire
01/21/2018 CITI Good Clinical Practice Course
11/19/2016 TransCelerate GCP Certificate
11/18-19/2016 Clinical Research Training for Physicians sponsored by Encore Research Group
RESEARCH EXPERIENCE WITH WCCR:
Principal Investigator:
2020-Present Enanta EDP305-102, NASH
2019-Present Next Science CSP-011, Non-Melanoma Skin Cancer Lesions
2019-Present Siemens Centaur-201902.Pro-CATCH-HF
2018-Present Acasti Pharma ACA-CAP-002, Hypertriglyceridemia
2018-2019 Enanta EDP 305-101, NASH
2017-2018 Gemphire Therapeutics GEM-401 (INDIGO-1), Hypertriglyceridemia
Sub-Investigator:
2020-Present GSK 212390, UTI
2019-Present Exact Sciences 2019-01, Colorectal Cancer Screening
2019-Present Novartis CTQJ230A12001, Lp(a)
2019-Present Sanofi Pasteur MEQ00066, Elderly meningococcal vaccine
2019-Present Novo Nordisk NN9536-4576, Obesity
2019-Present Allergan 3101-309-002 Episodic Migraines, Open Label Ext.
2019-Present Allergan 3101-301-002 Episodic Migraines
2018-Present Novo Nordisk NN9536-4378, STEP-5 Weight Loss
2018-Present Novo Nordisk NN9536-4374, STEP-2 Weight Loss/Diabetes
2018-Present GSK 207489 (NTHI MCAT-002), COPD
2018 Quantum Genomics QGC001-2QG3, HBP
2018-Present Novo Nordisk NN9536-4373, STEP-1 Weight Loss
2017-2018 Sanofi Pasteur QHD00013, Elderly Flu Vaccine
2017-2018 Novo Nordisk NN8022-4272 SCALE-INSULIN), Weight loss/diabetics
2017-2018 Esperion 1002-047, Lipids
2017-Present KOWA K-877-302, Hypertriglyceridemia
2016-Present Esperion 1002-043, Statin-intolerance
2016-2017 Takeda TMX-67_301, CV Comorbidities, Hyperuricemia & Gout
2016-2018 Amarin AMR-01-01-0019, Hypertriglyceridemia
2016-2018 Novo Nordisk NN5401-4266, Type 2 Diabetes
2016-2017 Sanofi EFC13794, Type 2 Diabetes
2016-Present Novo Nordisk 2211-4232, Type 2 Diabetes
2016-2018 Novo Nordisk NN8022-4274, Obesity
WORK EXPERIENCE:
2016-Present Clinical Investigator
Westside Center for Clinical Research
Jacksonville, FL
2016-Present Attending Physician
Baptist Primary Care
Jacksonville, FL
2012-2016 St. Vincent’s Primary Care, Branan Field
Middleburg, FL
2013-2016 Chairman of the Department of Medicine
St. Vincent’s Clay County
2013-2016 MSEC
St. Vincent’s Clay County
2010-2012 Attending Physician ER
Charlton Memorial Hospital
Folkston, GA
PUBLICATIONS:
Peer Reviewed Journal Articles/ Abstracts
A.M.S Mayer, Carlson, L.A., Braddock, M.T., McCulloch, P.F. Hippocampal C-Fos expression and microglia accumulation in rats exposed to the marine toxin domoic acid.. The Toxicologist 2007 Sep; 96(1): 364.
M.T. Braddock, L.A. Carlson, M.L. Hall, P.F. McCulloch and A.M.S. Mayer.. The effect of the marine toxin domoic acid on hippocampal c-FOS expression and microglia accumulation in rats.. JAOA.2007 Sep; 107(8): 347.
Poster Presentation
Matthew T. Braddock, (2007, October). The effect of the marine toxin domoic acid on hippocampal c-FOS expression and microglia accumulation in rats. Poster presented at : AOA Annual Convention and Scientific Seminar; San Diego, CA.
Exceptional care provided by EBGCR Clinical Research Principal Investigators
The Clinical Research Principal Investigators at Encore Borland Groover Clinical Research (EBGCR) strive to improve patient outcomes through cutting-edge clinical research. Our team of world-renowned specialists is committed to transforming medicine by conducting groundbreaking clinical trials. Our Clinical Research Principal Investigators are leaders in pharmacologic outcome clinical trials, particularly with new agents in Phases I-III. Our esteemed physicians can provide patients with early access to pioneering drugs by conducting clinical trials, which may only be available to the general public for a short time. With extensive clinical research expertise, our team advances medical knowledge daily and addresses serious health issues to enhance people’s lives today and tomorrow.
EBGCR Clinical Research Principal Investigators
904-680-0871
Expertise provided by Clinical Research Principal Investigators
At the heart of our mission to improve lives is the expertise and dedication of our Encore Borland Groover Clinical Research (EBGCR) Principal Investigators. They bring a wealth of knowledge and experience and are fueled by a deep passion for making a real difference in healthcare. Our investigators are committed to discovering and developing life-saving treatments with the potential to revolutionize patient care. Drawing on the latest advancements in medical research, our team is consistently at the forefront of innovation, exploring pioneering ways to improve outcomes and unlock new possibilities for patients worldwide. At EBGCR, we firmly believe that with our collective efforts, we can genuinely impact the lives of those we serve. Therefore, we are wholeheartedly dedicated to realizing our mission of delivering improved healthcare for all. Contact us to learn more about our mission.